ArticleJTO clinical and research reports2024

BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma.

Duo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.